Orchid Pharma OFS fully subscribed

The offer-for-sale in Orchid Pharma by its promoter received strong response from both non-institutional (HNI) and retail investors. While the HNI portion was subscribed by 1.14 times, the retail portion got subscribed 3.45 times.